Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Fierce Biotech
JPM26: Gilead eyes new deals from a 'position of strength'
Across virology, oncology and inflammation, Gilead has "the luxury of being selective" in the external assets it considers adding to its pipeline.
Darren Incorvaia
Jan 14, 2026 3:30am
Fierce Biotech
Study finds HIV can evolve to resist lenacapavir—at a cost
Jan 7, 2026 2:00pm
2024's top biopharma M&A deals
Brought to you by
Pfizer
9 pharmas reach US drug price deals with Trump administration
Dec 19, 2025 3:35pm
Gilead's single-tablet HIV combo passes 2nd late-stage test
Dec 16, 2025 9:15am
AZ, Gilead program helped Black breast cancer patients: study
Dec 10, 2025 3:00pm
